INTEGRA and COVID-19
-
Triaging and screening for COVID-19 symptoms
INTEGRA can be used to screen for COVID-19 symptoms and assess patients for potential exposure. A mobile application, and virtual telemedicine visits can be used to evaluate patients for COVID-19 symptoms, assess the severity of their symptoms, and decide whether the patient needs to be seen for evaluation, admitted to the hospital, or can be managed at home.
Decisions can also be made using INTEGRA AI and Rule Engine -when the rules are written by the client to set the thresholds for alerts. Alerts are displayed in dashboard and be customized by clients.
INTEGRA can also be used to screen patients before they visit the healthcare facility for non-COVID-19 care. If COVID-19 symptoms are reported during the telehealth interview, patients could be advised to delay non-emergent care and first seek testing for COVID-19
2. Contact Tracing
Telehealth, especially via phone, can be used to interview patients with COVID-19 to determine who they were in contact with during the time they were potentially infectious, and to follow-up with their contacts to inform them of the need to quarantine, assess whether they have any symptoms, and tell them what to do if symptoms develop.
All is then recorded in the patient file within INTEGRA and can be then integrated with the physician’s (or hospital’s) EMR.
3. Monitoring COVID-19 symptoms
Patients with mild or moderate COVID-19 symptoms can often isolate and be monitored at home to avoid overcrowding in healthcare facilities and save hospital beds for more severe cases.
Using telehealth technology such as phones or apps, healthcare providers can check in with patients frequently to monitor their condition, provide advice, and determine if the patient’s condition is deteriorating and they need to be evaluated for in-person care, such as hospitalization.
